News
With the stock currently priced at Rs 2,724.90, GlaxoSmithKline Pharmaceuticals shows significant activity in today's session ...
19h
TipRanks on MSNGSK Expands Share Buyback Programme with New Purchase
GlaxoSmithKline has announced the purchase of 306,478 of its own ordinary shares as part of its ongoing buyback programme. This transaction, executed through Merrill Lynch International, is part of a ...
GlaxoSmithKline (GSK) says Rowex Ltd is preparing to put on the market a product similar in its packaging to Glaxo's "Seretide" inhaler, which is the fourth highest selling pharmaceutical product ...
GlaxoSmithKline says it has built up a valuable intellectual property over the last 15 years in the use of “the unique and distinctive colour purple” on its Seretide inhaler.
1d
MONTCO Today on MSNWSJ: GSK to Receive $370M in CureVac-BioNTech Vaccine Dispute
Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street Journal. The pharmaceutical powerhouse will ...
In conclusion, GlaxoSmithKline's shares showed significant gains today, reflecting positive market sentiment and strong ...
Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...
Global drugs and health drinks company GlaxoSmithKline has been fined in New Zealand for misleading advertising after two science students found its iconic blackcurrant drink Ribena contained no ...
Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs for its inhalers at $35 a month, Sen. Maggie Hassan (D-N.H.) is accusing the company of circumventing that vow through ...
But GlaxoSmithKline's (GSK) chief executive, JP Garnier, believes that the group's strong product pipeline is helping it fight back. "We're able to take those hits and still move forward," he says. IC ...
(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies ...
How GlaxoSmithKline missed red flags in China By Ben Hirschler July 19, 20136:40 AM PDTUpdated July 19, 2013 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results